- E-mailgunnar.husebo@uib.no
- Visitor AddressHaukeland universitetssykehus, Laboratoriebygget5009 Bergen
- Postal AddressPostboks 78045020 Bergen
Academic article
- (2024). Lower airway microbiota in COPD and healthy controls. Thorax.
- (2022). A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease. PLOS ONE. 15 pages.
- (2021). The pulmonary mycobiome—A study of subjects with and without chronic obstructive pulmonary disease. PLOS ONE. 16 pages.
- (2020). The airway microbiota and exacerbations of COPD. European Respiratory Journal Open Research (ERJ Open Research). 1-10.
- (2020). Complications and discomfort after research bronchoscopy in the MicroCOPD study. BMJ Open Respiratory Research.
- (2020). Coagulation markers as predictors for clinical events in COPD. Respirology (Carlton South. Print). 1-10.
- (2019). Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study. Respiratory Medicine. 81-88.
- (2017). Protected sampling is preferable in bronchoscopic studies of the airway microbiome. European Respiratory Journal Open Research (ERJ Open Research).
- (2017). Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD. European Respiratory Journal. 1-10.
- (2016). Macrophage migration inhibitory factor, a role in COPD. American Journal of Physiology - Lung cellular and Molecular Physiology. L1-L7.
- (2014). The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences. European Clinical Respiratory Journal.
- (2014). Predictors of exacerbations in chronic obstructive pulmonary disease - results from the Bergen COPD Cohort Study. PLOS ONE.
Report
- (2017). Utvikling av indikatorer på NCD området knyttet til rapportering for den globale og nasjonale NCD strategien . .
More information in national current research information system (CRIStin)